An Efficient Test for Comparing Sequence Diversity between Two Populations
暂无分享,去创建一个
Peter B. Gilbert | Vladimir A. Novitsky | Monty A. Montano | Max Essex | P. Gilbert | M. Essex | V. Novitsky | M. Montano
[1] E. Lehmann,et al. Nonparametrics: Statistical Methods Based on Ranks , 1976 .
[2] J. Nkengasong,et al. The puzzle of HIV‐1 subtypes in Africa , 1997, AIDS.
[3] S. Zolla-Pazner,et al. The implications of antigenic diversity for vaccine development. , 1999, Immunology letters.
[4] Gilcher Ro. Human retroviruses and AIDS. , 1988 .
[5] S. Wain-Hobson. Virological mayhem , 1995, Nature.
[6] S. Eddy. Hidden Markov models. , 1996, Current opinion in structural biology.
[7] B. Korber,et al. Diversity of V3 region sequences of human immunodeficiency viruses type 1 from the central African Republic. , 1993, AIDS research and human retroviruses.
[8] Steven M. Wolinsky,et al. Adaptive Evolution of Human Immunodeficiency Virus-Type 1 During the Natural Course of Infection , 1996, Science.
[9] Lee-Jen Wei,et al. Combining dependent tests with incomplete repeated measurements , 1985 .
[10] B. Korber,et al. Signature pattern analysis: a method for assessing viral sequence relatedness. , 1992, AIDS research and human retroviruses.
[11] M. Essex. State of the HIV pandemic. , 1998, Journal of human virology.
[12] G. Learn,et al. Mother-to-infant transmission of human immunodeficiency virus type 1 involving five envelope sequence subtypes , 1997, Journal of virology.
[13] D. Burke,et al. Genetic variants of HIV-1 in Thailand. , 1992, AIDS research and human retroviruses.
[14] R. F. Smith,et al. Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1 , 1994, Journal of virology.
[15] P B Gilbert,et al. Statistical methods for assessing differential vaccine protection against human immunodeficiency virus types. , 1998, Biometrics.
[16] E. Pitman. TESTS OF HYPOTHESES CONCERNING LOCATION AND SCALE PARAMETERS , 1939 .
[17] S. Matsushita,et al. Characterization of proviral DNA from an individual with long-term, nonprogressive infection with HIV-1 and nonrecoverable virus. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[18] F. Vannberg,et al. Molecular Cloning and Phylogenetic Analysis of Human Immunodeficiency Virus Type 1 Subtype C: a Set of 23 Full-Length Clones from Botswana , 1999, Journal of Virology.
[19] A. Lapedes,et al. Covariation of mutations in the V3 loop of human immunodeficiency virus type 1 envelope protein: an information theoretic analysis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[20] E. Halapi,et al. Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[21] Subhash R. Lele,et al. Maximum likelihood estimation in semiparametric selection bias models with application to AIDS vaccine trials , 1999 .
[22] B. Korber,et al. Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group. , 1998, The Journal of infectious diseases.
[23] A. Fomsgaard,et al. HIV-1 DNA vaccines. , 1999, Immunology letters.
[24] D. Gotte,et al. Evolution and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple , 1997, Journal of virology.
[25] M H Gail,et al. Applicability of sample size calculations based on a comparison of proportions for use with the logrank test. , 1985, Controlled clinical trials.
[26] J. Goudsmit,et al. Genomic diversity and antigenic variation of HIV‐1: links between pathogenesis, epidemiology and vaccine development , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[27] C. Williamson,et al. An association between HIV‐1 subtypes and mode of transmission in Cape Town, South Africa , 1997, AIDS.
[28] C. Chappey,et al. Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission , 1995, Journal of virology.
[29] T. Wrin,et al. Genetic and immunologic characterization of viruses infecting MN-rgp120-vaccinated volunteers. , 1997, The Journal of infectious diseases.
[30] J. Mascola,et al. Diversity of the envelope glycoprotein among human immunodeficiency virus type 1 isolates of clade E from Asia and Africa , 1996, Journal of virology.
[31] W. Becker,et al. Analysis of partial gag and env gene sequences of HIV type 1 strains from southern Africa. , 1995, AIDS research and human retroviruses.
[32] A. Trkola,et al. Immunological and Virological Analyses of Persons Infected by Human Immunodeficiency Virus Type 1 while Participating in Trials of Recombinant gp120 Subunit Vaccines , 1998, Journal of Virology.
[33] P. Sonnenberg,et al. Genetic characterization of HIV type 1 from migrant workers in three South African gold mines. , 1998, AIDS research and human retroviruses.
[34] C. Williamson,et al. HIV-1 subtypes in different risk groups in South Africa , 1995, The Lancet.
[35] U. Pettersson,et al. Ugandan HIV-1 V3 loop sequences closely related to the U.S./European consensus. , 1992, Virology.